IRIS
FARINA, DEBORAH
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.555
EU - Europa 1.698
AS - Asia 1.648
SA - Sud America 220
AF - Africa 30
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 3
Totale 6.159
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.507
CN - Cina 559
SG - Singapore 554
UA - Ucraina 258
IE - Irlanda 255
GB - Regno Unito 203
TR - Turchia 181
BR - Brasile 180
RU - Federazione Russa 178
SE - Svezia 176
DE - Germania 163
FR - Francia 160
IT - Italia 149
VN - Vietnam 148
FI - Finlandia 78
IN - India 78
HK - Hong Kong 32
CA - Canada 28
CZ - Repubblica Ceca 17
JP - Giappone 17
AR - Argentina 16
MX - Messico 15
PL - Polonia 13
ZA - Sudafrica 13
ES - Italia 10
IR - Iran 10
BD - Bangladesh 9
IQ - Iraq 9
CH - Svizzera 7
CO - Colombia 7
NL - Olanda 7
ID - Indonesia 6
PK - Pakistan 6
PY - Paraguay 6
AE - Emirati Arabi Uniti 5
BE - Belgio 5
EU - Europa 5
JO - Giordania 5
LT - Lituania 5
MA - Marocco 5
SA - Arabia Saudita 5
EC - Ecuador 4
KR - Corea 4
RS - Serbia 4
TN - Tunisia 4
AU - Australia 3
CL - Cile 3
IL - Israele 3
KE - Kenya 3
NP - Nepal 3
BG - Bulgaria 2
BH - Bahrain 2
EG - Egitto 2
GR - Grecia 2
HR - Croazia 2
LB - Libano 2
PH - Filippine 2
UY - Uruguay 2
UZ - Uzbekistan 2
VE - Venezuela 2
AO - Angola 1
AT - Austria 1
AZ - Azerbaigian 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
ET - Etiopia 1
JM - Giamaica 1
LV - Lettonia 1
MD - Moldavia 1
MM - Myanmar 1
MY - Malesia 1
OM - Oman 1
PR - Porto Rico 1
RO - Romania 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TW - Taiwan 1
Totale 6.159
Salva come PNG Salva come JPEG
Città #
Singapore 422
Chandler 323
Jacksonville 307
Dublin 253
San Jose 229
Beijing 173
Ashburn 169
Dallas 166
Southend 152
Princeton 108
The Dalles 100
Izmir 92
Nanjing 89
Los Angeles 68
Dearborn 58
Wilmington 58
New York 56
Munich 54
Ho Chi Minh City 53
Cambridge 49
Santa Clara 49
Altamura 37
Tongling 36
Hanoi 33
Nanchang 33
Hong Kong 31
Moscow 29
Ann Arbor 28
Shenyang 21
São Paulo 20
Buffalo 17
Montreal 17
Chieti 16
Turku 15
Washington 15
Denver 14
Frankfurt am Main 14
Hebei 14
Jiaxing 14
Kunming 14
Tianjin 14
Boardman 13
Hangzhou 13
Helsinki 13
Tokyo 13
Woodbridge 13
Brno 12
Changsha 12
Grevenbroich 12
Redondo Beach 12
Warsaw 12
Atlanta 11
Jinan 11
Orem 11
Brooklyn 10
Norwalk 10
Poplar 10
Guangzhou 9
Mexico City 9
Stockholm 9
Ardabil 8
Augusta 8
Houston 8
Johannesburg 8
Monmouth Junction 8
Phoenix 8
Amsterdam 7
Boston 7
Camerino 7
Chennai 7
Chicago 7
Council Bluffs 7
Fermo 7
London 7
San Mateo 7
Campobasso 6
Da Nang 6
Fribourg 6
Hải Dương 6
Lanzhou 6
Manchester 6
Rio de Janeiro 6
San Francisco 6
Toronto 6
Amman 5
Biên Hòa 5
Brussels 5
Leawood 5
Ningbo 5
Baghdad 4
Belgrade 4
Brasília 4
Changchun 4
Curitiba 4
Hefei 4
Montesilvano Marina 4
Mumbai 4
Nuremberg 4
Olomouc 4
Porto Alegre 4
Totale 3.909
Salva come PNG Salva come JPEG
Nome #
Autologous hematopoietic stem cell transplantation in multiple sclerosis: A meta-analysis 164
A lipidomic investigation for the caracterisation of CSF lipid profile in patients with multiple sclerosis 160
Cognitive dysfunction in patients with relapsing-remitting Multiple Sclerosis 159
Acute myeloid leukemia in Italian patients with multiple sclerosis treated with mitoxantrone 155
Increasing age at disability milestones among MS patients in the MSBase Registry 152
Chemokines are Modulated by Interferon beta 1B (IFNT-Beta IB) in Relapsing-Remitting Multiple Sclerosis (RR-MS) 147
The Multiple Sclerosis Knowledge Questionnaire: a self administered instrument for recently diagnosed patients 147
Alemtuzumab treatment of multiple sclerosis in real-world clinical practice: A report from a single Italian center 147
Effetti sinergici della terapia con interferone-beta sulla attivazione, adesione ed apoptosi linfocitaria nella sclerosi multipla esacerbante/remittente 144
Metabolomics analysis of cerebrospinal fluid reveals a distintive biochemical alteration associated with multiple sclerosis. 139
An information aid for newly diagnosed multiple sclerosis patients improves disease knowledge and satisfaction with care. 138
Effetti sinergici della terapia con interferone-beta sulla attivazione. Adesione ed apoptosi linfocitaria nella sclerosi multipla esacerbante /remittente. (C22) 137
Development of methods for lipid extraction from CSF and application of mass spectometry techniques for the characterization of the lipid profile and neurosteroids levels in MS patients 137
Convulsive status epilepticus due to new encephalic demyelinating lesions in multiple sclerosis 134
A difficult pediatric case: ADEM evolving in multiple sclerosis complicated by progressive multifocal leukoencephalopathy after Natalizumab treatment. 131
Anti-JCV serostatus, index value and clinical features in patients affected by multiple sclerosis. 131
Autologous hematopoietic stem cell transplantation suppresses Gd-enhanced MRI activity in MS. 131
Brain tissue loss occurs after suppression of enhancement in patients with multiple scerosis treated with autologous haematopoietic stem cell transplantation. 129
The Kurtzke EDSS rank stability increases 4 years after the onset of multiple sclerosis: results from the MSBase Registry. 125
Country, Sex, EDSS Change and Therapy Choice Independently Predict Treatment Discontinuation in Multiple Sclerosis and Clinically Isolated Syndrome. 122
MCP-1 expression and secretion in adherent monocyte cultures from multiple sclerosis patients treated with interferon beta-1b 121
Experience of an information aid for newly diagnosed multiple sclerosis patients: a qualitative study on the SIMS-Trial 121
JCV-Ab serostatus in MS patients treated with Natalizumab 121
Development and validation of a patient self-assessed questionnaire on satisfaction with communication of the multiple sclerosis diagnosis. 121
Natalizumab treatment in multiple sclerosis patients: a multicenter experience in clinical practice in Italy. 120
The Chieti experience with Interferon B1b (IFNB1b) during the first 2 years: side effects. 119
Interferone beta: effetti collaterali 119
The Chieti Experience with interferon B1b (IFNB1b) during the first 2 years: Efficacy 115
Mass spectrometry based metabonomics of the cerebrospinalfluid highlights a correlation between polar lipids and carnitines levels in multiple sclerosis patients. 114
Multiphasic Adem or Multiple Sclerosis? Treatement implications. 112
Natalizumab-associated PML-IRIS: the Chieti experience. 110
Pregnancy outcomes and disease activity after exposure to natalizumab in patients with multiple sclerosis 110
Low dose oral methotrexate (MTX) in chronic progressive (CP) multiple sclerosis (MS) 110
Pregnancy outcomes and disease activity after exposure to natalizumab in patients with multiple sclerosis 109
Autologous stem cell transplantation for progressive multiple sclerosis: update of the European Group for Blood and Marrow Transplantation autoimmune diseases working party database. 109
Neuropsychological testing and quantitative electroencephalography: a search of neurophysiological markers of cognitive decline in multiple sclerosis 106
The long-term effect of AHSCT on MRI measures of MS evolution: a five-year follow-up study 106
Prevalence of JC virus antibodies in human serum and seroconversion rate with first-generation and second generation ELISA: the novel assay improves specificity andsensitivity to detect anti-JC virus antibodies 104
Autologous HSCT for severe progressive Multiple Sclerosis in a multicenter trial: impact on disease activity and quality of life 103
Real-life impact of early interferon beta therapy in relapsing multiple sclerosis 103
Treatment discontinuation issues in fingolimod treated patients: the Chieti experience. 94
Progressive multifocal leukoencephalopathy associated with natalizumab in paediatric multiple sclerosis 93
Neuropsychological testing and event-related potentials: markers of cognitive impairment in patients with multiple sclerosis 93
Defining the course of tumefactive multiple sclerosis: A large retrospective multicentre study 93
Lymphomononuclear cells from multiple scerosis patients spontaneously produce high levels of oncostatin M, tumor necrosis factors alpha and beta, and interferon gamma. 92
Pregnancy does not prevent disease re-activation after natalizumab suspension in patients with multiple sclerosis 92
Simultaneous early-onset severe autoimmune hemolytic anemia and albuminuria during alemtuzumab treatment for multiple sclerosis 91
Interferone beta1b: bilancio su un gruppo di 30 pazienti 89
Gender-related effect of clinical and genetic variables on the cognitive impairment in multiple sclerosis 89
Intense immunosuppression followed by autologous stem cell transplantation in severe multiple sclerosis 85
Multiple sclerosis in twins from continental Italy and Sardinia: a nationwide study 83
Long-term efficacy and tolerability of natalizumab treatment in multiple sclerosis patients: a multicentre experience in Italy 75
Spinal cord injury in a patient with multiple sclerosis (MS) with secondary hydromyelia 72
Totale 6.223
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.167
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.167
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202186 0 0 0 0 0 0 0 0 0 29 47 10
2021/2022213 1 4 6 49 6 2 6 19 12 3 31 74
2022/2023806 58 122 45 83 86 164 40 56 108 6 23 15
2023/2024397 34 18 25 6 29 164 72 3 1 7 2 36
2024/2025893 60 99 111 13 13 31 19 31 62 43 197 214
2025/20261.988 191 80 250 323 225 106 359 93 220 141 0 0
Totale 6.223